alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
To : "John V. Massingale" < j ohn@grcci.com>, Cc: Bcc: Subject: Re: Request for Modification of Test Schedule - Ethanedioic acid [CAS RN 144-62-7] From: Paul Campanella/DC/USEPA/US - Wednesday 10/31/2012 03:22 PM

John, After carefully considering your request for an extension of the time needed to complete testing and submit final reports to the EPA we are willing to grant this extension. Our decision is based on our extensive discussions with you and your cooperation in working with us to resolve the numerous issues that have surfaced as we worked through the nomenclature and approval of protocols.

Paul J. Campanella, Ph.D. Chemical Information and Testing Branch Chemical Control Division U.S. Environmental Protection Agency Washington, D.C. 202-564-8091

"John V. Massingale" 10/29/2012 04:54:30 PM ***This E-mail Contains No CBI***

From: "John V. Massingale" < j ohn@grcci.com> To: Paul Campanella/DC/USEPA/US@EPA Date: 10/29/2012 04:54 PM Subject: Request for Modification of Test Schedule - Ethanedioic acid [CAS RN 144-62-7]

***This E-mail Contains No CBI***

Dear Paul,

As we discussed last week, I include here a copy of the letter that is being sent overnight to EPA on behalf of the Oxalic Acid Testing Consortium comprised of Univar USA, Inc. and WEGO Chemical and Mineral Corporation. This letter requests a modification of test schedule for testing conducted by the Consortium under the TSCA Section 4 Test Rule (Second Group of HPV chemicals) for:

Ethanedioic acid ( Oxalic acid ) CAS RN 144-62-7]

Specifically, the letter requests a three-month extension due to nomenclature, study plan, and minor technical issues that have arisen in the course of this work.

We greatly appreciate the Agency's consideration in this matter. If there are any questions or comments, please do not hesitate to contact me.

Thank you,

John

_ ______________________________ John V. Massingale Greenwich Chemical Consulting, Inc. 3300 PGA Boulevard, Suite 635 Palm Beach Gardens, FL 33410T 561.578.8110 F 561.578.8120 E john@grcci.com www.grcci.com

EPA-Letter-October 2012-Final.pd f
To:

Cc:

Bcc:

Subject: Re: Response to PM Data Request - Slaughter et al

From: "'Lianne' Elizabeth Sheppard" <sheppard@u.washington.edu>

To: Beth Hassett-Sipple/RTP/USEPA/US@EPA

Cc: tlarson@u.washington.edu

Date: 07/20/2009 02:21 PM

Subject: Re: Fw: TO: Authors of recent U.S. and Canadian epidemiological studies evaluating health 

effects associated with exposure to fine and thoracic coarse particles REQUEST FOR PM AIR 

QUALITY DATA

My apologies for not responding to this request earlier. 

My understanding is that the estimates provided by Tim Larson 

for Spokane should apply to the Slaughter, Kim et al paper as 

well.

The estimates for Seattle provided for the Shildcrout et al 

paper on the CAMP study should apply to the Slaughter et al 

paper. While these are distinct analyses, the dataset for 

Seattle has the same origin. This feature should be taken into 

account in any compilation of health study results.

Please contact me if more information is needed.

--Lianne--

sheppard@u.washington.edu

Lianne Sheppard, Ph.D.

Professor

Box 357232

Department of Biostatistics

 (and Environmental and Occupational Health Sciences)

University of Washington

Seattle, WA 98195-7232

tel: (206)616-2722

fax: (206)543-3286

On Mon, 20 Jul 2009, Hassett-Sipple.Beth@epamail.epa.gov wrote:

> Drs. Sheppard and Larson, 

> 

> In May, EPA requested additional air quality data for a number of 

> epidemiological studies as part of our review of the PM NAAQS. The 

> purpose of this email is to again request PM2.5 and/or PM10-2.5 data for 

> the following studies:

> 

> Slaughter, J. C., E. Kim, et al. (2005). "Association between particulate 

> matter and emergency room visits, hospital admissions and mortality in 

> Spokane, Washington." J Expo Anal Environ Epidemiol 15(2): 153-9. 

> (Contact: Dr. Lianne Sheppard)

> 

> Slaughter, J. C., T. Lumley, et al. (2003). "Effects of ambient air 

> pollution on symptom severity and medication use in children with asthma." 

> Ann Allergy Asthma Immunol 91(4): 346-53. (Contact: Dr. Lianne Sheppard)

> 

> We would appreciate receiving the information requested below. Please 
> feel free to call me if you have any questions. Thank you in advance for

> your assistance with our request.

> 

> Regards,

> 

> Beth

> 

> Beth M. Hassett-Sipple 

> Environmental Health Scientist

> Ambient Standards Group (C504-06)

> Health and Environmental Impacts Division

> Office of Air Quality Planning and Standards

> U.S. Environmental Protection Agency

> 109 TW Alexander Drive

> RTP, NC 27711

> 

> (919) 541-4605

> Hassett-Sipple.Beth@epa.gov

> (919) 541-0237 (FAX)
<TABLE> <S> <C>

        <S> <C>
<PAGE>

<ARTICLE>    5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-K
FOR THE PERIOD ENDED DECEMBER 31, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>    1,000

<S>                                 <C>           <C>
<PERIOD-TYPE>                             12-MOS  <F1>
<FISCAL-YEAR-END>                    DEC-31-1999
<PERIOD-END>                         DEC-31-1999
<CASH>                                     1,752
<SECURITIES>                               2,988
<RECEIVABLES>                              2,414
<ALLOWANCES>                                 262
<INVENTORY>                                1,698
<CURRENT-ASSETS>                           9,359
<PP&E>                                     2,253
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                            15,508
<CURRENT-LIABILITIES>                      7,413
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                7,467
<COMMON>                                     130
<OTHER-SE>                                   473
<TOTAL-LIABILITY-AND-EQUITY>              15,508
<SALES>                                   18,817
<TOTAL-REVENUES>                          24,705
<CGS>                                     13,540
<TOTAL-COSTS>                             17,584
<OTHER-EXPENSES>                           6,188  <F2>
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                         (24,963)
<INCOME-TAX>                                  67
<INCOME-CONTINUING>                     (24,963)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                            (24,963)
<EPS-BASIC>                             (2.04)
<EPS-DILUTED>                             (2.04) <F3>



<FN>
<F1>  The Company changed its fiscal year end.  The reporting year ended
      January 1, 2000 is referred to herein as ending on December 31, 1999.
<F2>  Item consists of research and development.
<F3>  Item consists of basic earnings per share.
</FN>


</TABLE>
<PAGE>   1
                                                                  EXHIBIT 10.3

             AMENDED SCHEDULE OF MORTGAGES AND SECURITY AGREEMENTS,
           SECURED PROMISSORY NOTES, AND GUARANTIES ("LOAN DOCUMENTS")
       WHICH ARE SUBSTANTIALLY IN THE FORM OF KEY CORPORATE CAPITAL, INC.
      LOAN DOCUMENTS ATTACHED AS EXHIBITS 10.116, 10.117 AND 10.118 TO THE
              REGISTRANT'S FORM 10-K FOR THE PERIOD ENDING 12/31/99



<TABLE>
<CAPTION>

             MORTGAGOR                      FACILITY NAME               LOCATION                MORTGAGE       DATE OF
             ---------                      -------------               --------                --------       -------
                                                                                                AMOUNT         MORTGAGE
                                                                                                ------         --------

<S>                               <C>                                   <C>                     <C>            <C>
  Ithaca Bundy Road, LLC          Alterra Clare Bridge Cottage of       101 Bundy Road          $3,325,800     3/17/99
                                  Ithaca                                Ithaca, NY
                                                                        14850-9252

  Ithaca Trumansburg Road, LLC    Alterra Sterling House of Ithaca      103 Bundy Road          $2,862,608     3/17/99
                                                                        Ithaca, NY
                                                                        14850-9252

  Niagara Nash Road, LLC          Alterra Sterling House of Niagara     6751 Nash Road          $3,420,000     10/20/99
                                                                        North Tonawanda, NY
                                                                        14120

  Niagara SC Wheatfield, LLC      Alterra Clare Bridge Cottage of       6741 Nash Road          $3,367,010     10/20/99
                                  Niagara                               North Tonawanda, NY
                                                                        14120

  Clinton Brookside Drive, LLC    Alterra Clare Bridge Cottage of       115 Brookside Drive     $3,300,000     1/14/00
                                  Clinton                               Clinton, NY  13323

  Glastonbury Fairway Crossing,   Alterra Clare Bridge of               1824 Manchester Road    $5,447,129     4/21/00
  LLC                             Glastonbury                           Glastonbury, CT

</TABLE>
**Exhibit 31.2**Certification of Chief Financial Officer pursuant to Rules13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934,as amended
**CERTIFICATION**
I, Matthew M. Loar, certify that:
     1. I have reviewed this annual report on Form 10-K of GenelabsTechnologies, Inc.;
     2. Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material fact necessary to makethe statements made, in light of the circumstances under which such statementswere made, not misleading with respect to the period covered by this report;
     3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrantas of, and for, the periods presented in this report;
     4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and we have:
          a) Designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in whichthis report is being prepared;
          b) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions aboutthe effectiveness of the disclosure controls and procedures as of the endof the period covered by this report based on such evaluation; and
          c) Disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter that has materially affected, oris reasonably likely to materially affect, the registrant’s internalcontrol over financial reporting; and
     5. The registrant’s other certifying officers and I have disclosed,based on our most recent evaluation, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing theequivalent function):
          a) All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and
          b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internalcontrol over financial reporting.   Date: March 15, 2004 /s/ Matthew M. Loar   Matthew M. Loar
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                          97,332
<SECURITIES>                                         0
<RECEIVABLES>                                  985,482
<ALLOWANCES>                                         0
<INVENTORY>                                  2,669,221
<CURRENT-ASSETS>                             3,923,923
<PP&E>                                         400,092
<DEPRECIATION>                                 106,612
<TOTAL-ASSETS>                               4,490,550
<CURRENT-LIABILITIES>                        1,799,424
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,150
<OTHER-SE>                                   2,687,976
<TOTAL-LIABILITY-AND-EQUITY>                 4,490,550
<SALES>                                      4,832,935
<TOTAL-REVENUES>                             4,832,935
<CGS>                                        2,311,545
<TOTAL-COSTS>                                3,500,346
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              25,214
<INCOME-PRETAX>                              (992,008)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (992,008)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (992,008)
<EPS-PRIMARY>                                     0.31
<EPS-DILUTED>                                     0.31
        

</TABLE>
<PAGE>   1
                                                                     EXHIBIT 2.2

G. Michael Curran
David F. Staber
Akin, Gump, Strauss, Hauer & Feld, L.L.P.
1700 Pacific Ave., #4100
Dallas, TX 75201-4618
Telephone: (214)969-2800
Facsimile: (214)969-4343
ATTORNEYS TO FIRST CITY LIQUIDATING TRUST


                     IN THE UNITED STATES BANKRUPTCY COURT
                       FOR THE NORTHERN DISTRICT OF TEXAS
                                DALLAS DIVISION


IN RE                                  )
                                       )
FIRST CITY BANCORPORATION              )          CASE NO. 392-39474-HCA-11
OF TEXAS, INC.,                        )          CHAPTER 11
                                       )
          DEBTOR.                      )          HEARING SET: JUNE 18, 1999
                                       )                         9:15 A.M.

                            ORDER EXTENDING TERM OF
                          FIRST CITY LIQUIDATING TRUST

     On June 18, 1999, came on to be heard State Street Bank and Trust Company
of Connecticut, N.A., Trustee of First City Liquidating Trust's Second Motion
to Extend Term of First City Liquidating Trust, and after reviewing the
pleadings, evidence and arguments of counsel, the Court is of the opinion that
the Trust should be extended; IT IS THEREFORE

     ORDERED that the term of First City Liquidating Trust shall be extended
through and including January 3, 2002.

     SIGNED this 18 day of June, 1999.


                                             /s/ HAROLD C. ABRAMSON
                                             ------------------------------
                                             HAROLD C. ABRAMSON
                                             UNITED STATES BANKRUPTCY JUDGE
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet and consolidated statements of operations of Alterra
Healthcare Corporation filed with the Company's Form 10-Q for the period ended
September 30, 2000 and is qualified in its entirety by reference to such
financial statements and related footnotes.
</LEGEND>
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          46,858
<SECURITIES>                                         0
<RECEIVABLES>                                    9,229
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               180,078
<PP&E>                                       1,039,026
<DEPRECIATION>                                (64,633)
<TOTAL-ASSETS>                               1,285,366
<CURRENT-LIABILITIES>                          167,915
<BONDS>                                        981,844
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       179,442
<OTHER-SE>                                    (63,823)
<TOTAL-LIABILITY-AND-EQUITY>                 1,285,366
<SALES>                                        341,178
<TOTAL-REVENUES>                               341,178
<CGS>                                                0
<TOTAL-COSTS>                                  338,360
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              53,713
<INCOME-PRETAX>                               (66,145)
<INCOME-TAX>                                    22,563
<INCOME-CONTINUING>                           (43,582)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  8,536
<CHANGES>                                            0
<NET-INCOME>                                  (35,046)
<EPS-BASIC>                                     (1.58)
<EPS-DILUTED>                                   (1.58)


</TABLE>
<PAGE>   1
                                                                     EXHIBIT 11


                         INTERLOTT TECHNOLOGIES, INC.
                       COMPUTATION OF EARNING PER SHARE

<TABLE>
<CAPTION>

                               THREE MONTHS ENDED            YEAR ENDED
                                   DECEMBER 31,              DECEMBER 31,

                                1997         1996         1997          1996
                                ----         ----         ----          ----

<S>                           <C>         <S>           <C>           <C>
Weighted average common
shares outstanding during
the period                     3,210,000    3,210,000    3,210,000     3,210,000

Net income                       436,709   $  726,384   $1,451,654    $1,320,597

 Net income per share        $      0.14   $     0.13   $     0.45    $     0.41

Assuming full dilution:
 Weighted average common
  shares outstanding during
  the period                  3,210,000     3,210,000    3,210,000     3,210,000

Assuming exercise of
 options                          4,870         2,000        2,661         2,000

Weighted average common
 shares outstanding as
 adjusted                     3,214,870     3,212,000    3,212,661     3,212,000

Net income                   $  436,709    $  726,384   $1,451,654    $1,320,597

Earning per common share
 assuming full dilution      $     0.14    $     0.13   $     0.45    $     0.41
</TABLE>
#### ROBERTS v. STATE.

No. 20275.

Court of Criminal Appeals of Texas.

March 29, 1939.

Aubrey Davee, of Brady, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

CHRISTIAN, Judge.

The offense is selling beer in a dry area.

The transcript fails to show that appellant entered into a recognizance or gave an appeal bond. The affidavit of the sheriff of McCulloch County on file herein states that appellant has been at liberty at all times since his conviction, and that he entered into no recognizance during the *648term at which he was convicted and gave no appeal bond after the adjournment of said term. Under the circumstances, this court is without jurisdiction.

The appeal is dismissed.

PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the Judges of the Court of Criminal Appeals and approved by the Court.
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 22-0611

STATE OF MONTANA, 

Plaintiff and Appellee, 

v. 

RANDALL PATRICK ATKINS,

Defendant and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, 

and good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including March 13, 2024, within which to prepare, file, 

and serve Appellant’s opening brief on appeal.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

February 5 2024

02/05/2024

Case Number: DA 22-0611
1

This is a draft document and does not represent a definitive view of the agency on the questions addressed

. This and other guidance documents are accessible on the U.S. Department of Energy, Energy Efficiency & Renewable Energy web site at: http://www1.eere.energy.gov/guidance/default.aspx?pid=2&spid=1

.

Guidance Type: Certification and CCMS, Test Procedures, Enforcement, Definitions and Scope of Coverage Category: Plumbing Products Product: Faucets Guidance Version: DRAFT Issued: May 22, 2014 Comment Period Ends: June 23, 2014

The following is a draft U.S. Department of Energy (DOE or the Department) guidance document regarding the test procedure for faucets. This draft guidance document represe nts the Department’s interpretation of its existing regulations and is exempt from the notice and comment requirements of the Administrative Procedure Act. See 5 U.S.C. § 553(b)(A). Nonetheless, the Department is accepting comments and suggestions from the public until June 23, 2014. Comments and suggestions should be provided in WordPerfect, Microsoft Word, PDF, or text file format by sending an email to FaucetGuidance2014GUID0023 @ee.doe.gov

. Please also include the docket number EERE

- 2014

- BT

GUID

- 0023. At the end of the comment period, this draft guidance document may be adopted, revised, or withdrawn.

Q: Can a replacement aerator be tested with a fauce t model or other test device with which it is not itself distributed in commerce ?

A: Yes

. T he rated water use of a basic model of replacement aerator must be derived from a test of the covered product, which is the replacement aerator

. Because the faucet or other device to which a replacement aerator is attached is not part of the basic model of replacement aerator, any faucet or othe r testing device may be used for testing the water consumption of a replacement aerator as long as the test is ot herwise consistent with the required DOE test procedure

.
This FAQ may also be of interest:
http://www1.eere.energy.gov/buildings/app liance_standards/pdfs/faucet_flow

- insert

- tests_faq_2014

- 05

- 22.pdf